|
|
|
|
| Welcome to Nanjing MeiRui Pharma Co. Ltd. |
|
| Nanjing MeiRui Pharma Co. Ltd (MeiRui). MeiRui is a leading Chinese ethical pharmaceutical and diagnostics company specializing in drugs to treat benign prostatic hyperplasia (BPH) and prostates, and other urology pharmaceuticals, urology diagnostic products and urology devices. |
|
|
|
|
| |
| Latest News |
 |
|
|
|
|
|
|
|
| |
>> Prostat |
|
| |
Prostat is indicated in the treatment of symptoms of BPH and prostatitis. It is the only therapeutic that treats both conditions. Benign prostatic hyperplasia (BPH), chronic non-bacteria prostatitis and prostatodynia are the most common urinary diseases among elderly men |
|
| |
more |
|
| |
|
|
| |
>> Sheniting |
|
| |
Sheniting indicated for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence. This is a a condition effecting 10% of the population. Overactive bladder is most prevelent in women. |
|
| |
more |
|
| |
|
|
| |
>> ImmunoCAP |
|
| |
ImmunoCAP is a complete and comprehensive allergy diagnostic system. The ImmunoCAP system allows physicians to determine the exact cause or causes of the allergies and asthmas that affect a high percentage of the population. |
|
| |
more |
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
| About MeiRui |
 |
| |
|
|
| |
Our Mission |
|
| |
MeiRui's mission is to provide people suffering from diseases with the best products and services available. |
|
| |
more |
|
| |
Our Goal |
|
| |
MeiRui's goal is to be a leading Chinese pharmaceutical and diagnostic company in the field of urology, |
|
| |
more |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
